Phase II Trial Evaluating The Efficacy Of A Multiepitope Dendritic Cell Vaccine Given With Trastuzumab And Vinorelbine For The Treatment Of Women With Metastatic Breast Cancer That Express HLA-A020.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cancer vaccines; Trastuzumab; Vinorelbine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 20 Jun 2017 Biomarkers information updated
- 21 Feb 2012 Actual end date (Oct 2009 ) added as reported by ClinicalTrials.gov.
- 17 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.